Novartis Ag (NVS) Cash from Discontinued Operations (2016 - 2025)
Historic Cash from Discontinued Operations for Novartis Ag (NVS) over the last 7 years, with Q4 2023 value amounting to $164.0 million.
- Novartis Ag's Cash from Discontinued Operations fell 5218.66% to $164.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $402.0 million, marking a year-over-year decrease of 4904.94%. This contributed to the annual value of $238.0 million for FY2023, which is 8011.7% down from last year.
- According to the latest figures from Q4 2023, Novartis Ag's Cash from Discontinued Operations is $164.0 million, which was down 5218.66% from $74.0 million recorded in Q3 2023.
- In the past 5 years, Novartis Ag's Cash from Discontinued Operations registered a high of $499.0 million during Q2 2019, and its lowest value of $59.0 million during Q2 2023.
- Its 3-year average for Cash from Discontinued Operations is $221.0 million, with a median of $134.5 million in 2023.
- In the last 5 years, Novartis Ag's Cash from Discontinued Operations soared by 1604.65% in 2019 and then crashed by 8340.81% in 2023.
- Quarter analysis of 3 years shows Novartis Ag's Cash from Discontinued Operations stood at $499.0 million in 2019, then tumbled by 31.26% to $343.0 million in 2022, then tumbled by 52.19% to $164.0 million in 2023.
- Its last three reported values are $164.0 million in Q4 2023, $74.0 million for Q3 2023, and $59.0 million during Q2 2023.